Global Monoclonal Mouse Antibody Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by Cйsar Milstein and Georges Kцhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
According to APO Research, The global Monoclonal Mouse Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Monoclonal Mouse Antibody include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Monoclonal Mouse Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Monoclonal Mouse Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Monoclonal Mouse Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Monoclonal Mouse Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Monoclonal Mouse Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Monoclonal Mouse Antibody sales, projected growth trends, production technology, application and end-user industry.
Monoclonal Mouse Antibody segment by Company
1. To analyze and research the global Monoclonal Mouse Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Monoclonal Mouse Antibody market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Monoclonal Mouse Antibody significant trends, drivers, influence factors in global and regions.
6. To analyze Monoclonal Mouse Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Mouse Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Mouse Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Mouse Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Monoclonal Mouse Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Monoclonal Mouse Antibody industry.
Chapter 3: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Monoclonal Mouse Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Monoclonal Mouse Antibody in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by Cйsar Milstein and Georges Kцhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
According to APO Research, The global Monoclonal Mouse Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Monoclonal Mouse Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Monoclonal Mouse Antibody include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Monoclonal Mouse Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Monoclonal Mouse Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Monoclonal Mouse Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Monoclonal Mouse Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Monoclonal Mouse Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Monoclonal Mouse Antibody sales, projected growth trends, production technology, application and end-user industry.
Monoclonal Mouse Antibody segment by Company
- Roche
- Johnson & Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
- IgM
- IgG
- IgA
- Others
- Therapeutic
- Research
- Diagnostic
- ELISA kits
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Monoclonal Mouse Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Monoclonal Mouse Antibody market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Monoclonal Mouse Antibody significant trends, drivers, influence factors in global and regions.
6. To analyze Monoclonal Mouse Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Mouse Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Mouse Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Mouse Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Monoclonal Mouse Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Monoclonal Mouse Antibody industry.
Chapter 3: Detailed analysis of Monoclonal Mouse Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Monoclonal Mouse Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Monoclonal Mouse Antibody in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Monoclonal Mouse Antibody Sales Value (2019-2030)
1.2.2 Global Monoclonal Mouse Antibody Sales Volume (2019-2030)
1.2.3 Global Monoclonal Mouse Antibody Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 MONOCLONAL MOUSE ANTIBODY MARKET DYNAMICS
2.1 Monoclonal Mouse Antibody Industry Trends
2.2 Monoclonal Mouse Antibody Industry Drivers
2.3 Monoclonal Mouse Antibody Industry Opportunities and Challenges
2.4 Monoclonal Mouse Antibody Industry Restraints
3 MONOCLONAL MOUSE ANTIBODY MARKET BY COMPANY
3.1 Global Monoclonal Mouse Antibody Company Revenue Ranking in 2023
3.2 Global Monoclonal Mouse Antibody Revenue by Company (2019-2024)
3.3 Global Monoclonal Mouse Antibody Sales Volume by Company (2019-2024)
3.4 Global Monoclonal Mouse Antibody Average Price by Company (2019-2024)
3.5 Global Monoclonal Mouse Antibody Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Monoclonal Mouse Antibody Company Manufacturing Base & Headquarters
3.7 Global Monoclonal Mouse Antibody Company, Product Type & Application
3.8 Global Monoclonal Mouse Antibody Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Monoclonal Mouse Antibody Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Monoclonal Mouse Antibody Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 MONOCLONAL MOUSE ANTIBODY MARKET BY TYPE
4.1 Monoclonal Mouse Antibody Type Introduction
4.1.1 IgM
4.1.2 IgG
4.1.3 IgA
4.1.4 Others
4.2 Global Monoclonal Mouse Antibody Sales Volume by Type
4.2.1 Global Monoclonal Mouse Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Monoclonal Mouse Antibody Sales Volume by Type (2019-2030)
4.2.3 Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2030)
4.3 Global Monoclonal Mouse Antibody Sales Value by Type
4.3.1 Global Monoclonal Mouse Antibody Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Monoclonal Mouse Antibody Sales Value by Type (2019-2030)
4.3.3 Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2030)
5 MONOCLONAL MOUSE ANTIBODY MARKET BY APPLICATION
5.1 Monoclonal Mouse Antibody Application Introduction
5.1.1 Therapeutic
5.1.2 Research
5.1.3 Diagnostic
5.1.4 ELISA kits
5.2 Global Monoclonal Mouse Antibody Sales Volume by Application
5.2.1 Global Monoclonal Mouse Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Monoclonal Mouse Antibody Sales Volume by Application (2019-2030)
5.2.3 Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2030)
5.3 Global Monoclonal Mouse Antibody Sales Value by Application
5.3.1 Global Monoclonal Mouse Antibody Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Monoclonal Mouse Antibody Sales Value by Application (2019-2030)
5.3.3 Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2030)
6 MONOCLONAL MOUSE ANTIBODY MARKET BY REGION
6.1 Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Monoclonal Mouse Antibody Sales by Region (2019-2030)
6.2.1 Global Monoclonal Mouse Antibody Sales by Region: 2019-2024
6.2.2 Global Monoclonal Mouse Antibody Sales by Region (2025-2030)
6.3 Global Monoclonal Mouse Antibody Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Monoclonal Mouse Antibody Sales Value by Region (2019-2030)
6.4.1 Global Monoclonal Mouse Antibody Sales Value by Region: 2019-2024
6.4.2 Global Monoclonal Mouse Antibody Sales Value by Region (2025-2030)
6.5 Global Monoclonal Mouse Antibody Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Monoclonal Mouse Antibody Sales Value (2019-2030)
6.6.2 North America Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Monoclonal Mouse Antibody Sales Value (2019-2030)
6.7.2 Europe Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Monoclonal Mouse Antibody Sales Value (2019-2030)
6.8.2 Asia-Pacific Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Monoclonal Mouse Antibody Sales Value (2019-2030)
6.9.2 Latin America Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Monoclonal Mouse Antibody Sales Value (2019-2030)
6.10.2 Middle East & Africa Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
7 MONOCLONAL MOUSE ANTIBODY MARKET BY COUNTRY
7.1 Global Monoclonal Mouse Antibody Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Monoclonal Mouse Antibody Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Monoclonal Mouse Antibody Sales by Country (2019-2030)
7.3.1 Global Monoclonal Mouse Antibody Sales by Country (2019-2024)
7.3.2 Global Monoclonal Mouse Antibody Sales by Country (2025-2030)
7.4 Global Monoclonal Mouse Antibody Sales Value by Country (2019-2030)
7.4.1 Global Monoclonal Mouse Antibody Sales Value by Country (2019-2024)
7.4.2 Global Monoclonal Mouse Antibody Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.5.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.6.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.7.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.8.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.9.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.10.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.11.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.12.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.13.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.14.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.15.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.16.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.17.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.18.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.19.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.20.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.21.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.22.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.23.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
8.1.5 Roche Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
8.3.5 Merck Recent Developments
8.4 Novartis
8.4.1 Novartis Comapny Information
8.4.2 Novartis Business Overview
8.4.3 Novartis Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
8.4.5 Novartis Recent Developments
8.5 AbbVie
8.5.1 AbbVie Comapny Information
8.5.2 AbbVie Business Overview
8.5.3 AbbVie Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
8.5.5 AbbVie Recent Developments
8.6 Amgen
8.6.1 Amgen Comapny Information
8.6.2 Amgen Business Overview
8.6.3 Amgen Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
8.6.5 Amgen Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.7.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
8.8.5 Bayer Recent Developments
8.9 Lilly
8.9.1 Lilly Comapny Information
8.9.2 Lilly Business Overview
8.9.3 Lilly Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
8.9.5 Lilly Recent Developments
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Comapny Information
8.10.2 Bristol-Myers Squibb Business Overview
8.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
8.10.5 Bristol-Myers Squibb Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
8.12 Biogen
8.12.1 Biogen Comapny Information
8.12.2 Biogen Business Overview
8.12.3 Biogen Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
8.12.5 Biogen Recent Developments
8.13 AstraZeneca
8.13.1 AstraZeneca Comapny Information
8.13.2 AstraZeneca Business Overview
8.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
8.13.5 AstraZeneca Recent Developments
8.14 Sanofi
8.14.1 Sanofi Comapny Information
8.14.2 Sanofi Business Overview
8.14.3 Sanofi Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
8.14.5 Sanofi Recent Developments
8.15 Alexion Pharmaceuticals
8.15.1 Alexion Pharmaceuticals Comapny Information
8.15.2 Alexion Pharmaceuticals Business Overview
8.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
8.15.5 Alexion Pharmaceuticals Recent Developments
8.16 Seattle Genetics
8.16.1 Seattle Genetics Comapny Information
8.16.2 Seattle Genetics Business Overview
8.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
8.16.5 Seattle Genetics Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Monoclonal Mouse Antibody Value Chain Analysis
9.1.1 Monoclonal Mouse Antibody Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Monoclonal Mouse Antibody Sales Mode & Process
9.2 Monoclonal Mouse Antibody Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Monoclonal Mouse Antibody Distributors
9.2.3 Monoclonal Mouse Antibody Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Monoclonal Mouse Antibody Sales Value (2019-2030)
1.2.2 Global Monoclonal Mouse Antibody Sales Volume (2019-2030)
1.2.3 Global Monoclonal Mouse Antibody Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 MONOCLONAL MOUSE ANTIBODY MARKET DYNAMICS
2.1 Monoclonal Mouse Antibody Industry Trends
2.2 Monoclonal Mouse Antibody Industry Drivers
2.3 Monoclonal Mouse Antibody Industry Opportunities and Challenges
2.4 Monoclonal Mouse Antibody Industry Restraints
3 MONOCLONAL MOUSE ANTIBODY MARKET BY COMPANY
3.1 Global Monoclonal Mouse Antibody Company Revenue Ranking in 2023
3.2 Global Monoclonal Mouse Antibody Revenue by Company (2019-2024)
3.3 Global Monoclonal Mouse Antibody Sales Volume by Company (2019-2024)
3.4 Global Monoclonal Mouse Antibody Average Price by Company (2019-2024)
3.5 Global Monoclonal Mouse Antibody Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Monoclonal Mouse Antibody Company Manufacturing Base & Headquarters
3.7 Global Monoclonal Mouse Antibody Company, Product Type & Application
3.8 Global Monoclonal Mouse Antibody Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Monoclonal Mouse Antibody Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Monoclonal Mouse Antibody Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 MONOCLONAL MOUSE ANTIBODY MARKET BY TYPE
4.1 Monoclonal Mouse Antibody Type Introduction
4.1.1 IgM
4.1.2 IgG
4.1.3 IgA
4.1.4 Others
4.2 Global Monoclonal Mouse Antibody Sales Volume by Type
4.2.1 Global Monoclonal Mouse Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Monoclonal Mouse Antibody Sales Volume by Type (2019-2030)
4.2.3 Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2030)
4.3 Global Monoclonal Mouse Antibody Sales Value by Type
4.3.1 Global Monoclonal Mouse Antibody Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Monoclonal Mouse Antibody Sales Value by Type (2019-2030)
4.3.3 Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2030)
5 MONOCLONAL MOUSE ANTIBODY MARKET BY APPLICATION
5.1 Monoclonal Mouse Antibody Application Introduction
5.1.1 Therapeutic
5.1.2 Research
5.1.3 Diagnostic
5.1.4 ELISA kits
5.2 Global Monoclonal Mouse Antibody Sales Volume by Application
5.2.1 Global Monoclonal Mouse Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Monoclonal Mouse Antibody Sales Volume by Application (2019-2030)
5.2.3 Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2030)
5.3 Global Monoclonal Mouse Antibody Sales Value by Application
5.3.1 Global Monoclonal Mouse Antibody Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Monoclonal Mouse Antibody Sales Value by Application (2019-2030)
5.3.3 Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2030)
6 MONOCLONAL MOUSE ANTIBODY MARKET BY REGION
6.1 Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Monoclonal Mouse Antibody Sales by Region (2019-2030)
6.2.1 Global Monoclonal Mouse Antibody Sales by Region: 2019-2024
6.2.2 Global Monoclonal Mouse Antibody Sales by Region (2025-2030)
6.3 Global Monoclonal Mouse Antibody Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Monoclonal Mouse Antibody Sales Value by Region (2019-2030)
6.4.1 Global Monoclonal Mouse Antibody Sales Value by Region: 2019-2024
6.4.2 Global Monoclonal Mouse Antibody Sales Value by Region (2025-2030)
6.5 Global Monoclonal Mouse Antibody Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Monoclonal Mouse Antibody Sales Value (2019-2030)
6.6.2 North America Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Monoclonal Mouse Antibody Sales Value (2019-2030)
6.7.2 Europe Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Monoclonal Mouse Antibody Sales Value (2019-2030)
6.8.2 Asia-Pacific Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Monoclonal Mouse Antibody Sales Value (2019-2030)
6.9.2 Latin America Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Monoclonal Mouse Antibody Sales Value (2019-2030)
6.10.2 Middle East & Africa Monoclonal Mouse Antibody Sales Value Share by Country, 2023 VS 2030
7 MONOCLONAL MOUSE ANTIBODY MARKET BY COUNTRY
7.1 Global Monoclonal Mouse Antibody Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Monoclonal Mouse Antibody Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Monoclonal Mouse Antibody Sales by Country (2019-2030)
7.3.1 Global Monoclonal Mouse Antibody Sales by Country (2019-2024)
7.3.2 Global Monoclonal Mouse Antibody Sales by Country (2025-2030)
7.4 Global Monoclonal Mouse Antibody Sales Value by Country (2019-2030)
7.4.1 Global Monoclonal Mouse Antibody Sales Value by Country (2019-2024)
7.4.2 Global Monoclonal Mouse Antibody Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.5.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.6.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.7.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.8.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.9.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.10.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.11.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.12.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.13.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.14.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.15.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.16.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.17.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.18.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.19.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.20.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.21.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.22.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030)
7.23.2 Global Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.1.4 Roche Monoclonal Mouse Antibody Product Portfolio
8.1.5 Roche Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.3.4 Merck Monoclonal Mouse Antibody Product Portfolio
8.3.5 Merck Recent Developments
8.4 Novartis
8.4.1 Novartis Comapny Information
8.4.2 Novartis Business Overview
8.4.3 Novartis Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.4.4 Novartis Monoclonal Mouse Antibody Product Portfolio
8.4.5 Novartis Recent Developments
8.5 AbbVie
8.5.1 AbbVie Comapny Information
8.5.2 AbbVie Business Overview
8.5.3 AbbVie Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.5.4 AbbVie Monoclonal Mouse Antibody Product Portfolio
8.5.5 AbbVie Recent Developments
8.6 Amgen
8.6.1 Amgen Comapny Information
8.6.2 Amgen Business Overview
8.6.3 Amgen Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.6.4 Amgen Monoclonal Mouse Antibody Product Portfolio
8.6.5 Amgen Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.7.4 Pfizer Monoclonal Mouse Antibody Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.8.4 Bayer Monoclonal Mouse Antibody Product Portfolio
8.8.5 Bayer Recent Developments
8.9 Lilly
8.9.1 Lilly Comapny Information
8.9.2 Lilly Business Overview
8.9.3 Lilly Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.9.4 Lilly Monoclonal Mouse Antibody Product Portfolio
8.9.5 Lilly Recent Developments
8.10 Bristol-Myers Squibb
8.10.1 Bristol-Myers Squibb Comapny Information
8.10.2 Bristol-Myers Squibb Business Overview
8.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.10.4 Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
8.10.5 Bristol-Myers Squibb Recent Developments
8.11 GlaxoSmithKline
8.11.1 GlaxoSmithKline Comapny Information
8.11.2 GlaxoSmithKline Business Overview
8.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.11.4 GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
8.11.5 GlaxoSmithKline Recent Developments
8.12 Biogen
8.12.1 Biogen Comapny Information
8.12.2 Biogen Business Overview
8.12.3 Biogen Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.12.4 Biogen Monoclonal Mouse Antibody Product Portfolio
8.12.5 Biogen Recent Developments
8.13 AstraZeneca
8.13.1 AstraZeneca Comapny Information
8.13.2 AstraZeneca Business Overview
8.13.3 AstraZeneca Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.13.4 AstraZeneca Monoclonal Mouse Antibody Product Portfolio
8.13.5 AstraZeneca Recent Developments
8.14 Sanofi
8.14.1 Sanofi Comapny Information
8.14.2 Sanofi Business Overview
8.14.3 Sanofi Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.14.4 Sanofi Monoclonal Mouse Antibody Product Portfolio
8.14.5 Sanofi Recent Developments
8.15 Alexion Pharmaceuticals
8.15.1 Alexion Pharmaceuticals Comapny Information
8.15.2 Alexion Pharmaceuticals Business Overview
8.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.15.4 Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
8.15.5 Alexion Pharmaceuticals Recent Developments
8.16 Seattle Genetics
8.16.1 Seattle Genetics Comapny Information
8.16.2 Seattle Genetics Business Overview
8.16.3 Seattle Genetics Monoclonal Mouse Antibody Sales, Value and Gross Margin (2019-2024)
8.16.4 Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
8.16.5 Seattle Genetics Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Monoclonal Mouse Antibody Value Chain Analysis
9.1.1 Monoclonal Mouse Antibody Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Monoclonal Mouse Antibody Sales Mode & Process
9.2 Monoclonal Mouse Antibody Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Monoclonal Mouse Antibody Distributors
9.2.3 Monoclonal Mouse Antibody Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Monoclonal Mouse Antibody Industry Trends
Table 2. Monoclonal Mouse Antibody Industry Drivers
Table 3. Monoclonal Mouse Antibody Industry Opportunities and Challenges
Table 4. Monoclonal Mouse Antibody Industry Restraints
Table 5. Global Monoclonal Mouse Antibody Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Monoclonal Mouse Antibody Revenue Share by Company (2019-2024)
Table 7. Global Monoclonal Mouse Antibody Sales Volume by Company (Kg) & (2019-2024)
Table 8. Global Monoclonal Mouse Antibody Sales Volume Share by Company (2019-2024)
Table 9. Global Monoclonal Mouse Antibody Average Price (USD/g) of Company (2019-2024)
Table 10. Global Monoclonal Mouse Antibody Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Monoclonal Mouse Antibody Key Company Manufacturing Base & Headquarters
Table 12. Global Monoclonal Mouse Antibody Company, Product Type & Application
Table 13. Global Monoclonal Mouse Antibody Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Monoclonal Mouse Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of IgM
Table 18. Major Companies of IgG
Table 19. Major Companies of IgA
Table 20. Major Companies of Others
Table 21. Global Monoclonal Mouse Antibody Sales Volume by Type 2019 VS 2023 VS 2030 (Kg)
Table 22. Global Monoclonal Mouse Antibody Sales Volume by Type (2019-2024) & (Kg)
Table 23. Global Monoclonal Mouse Antibody Sales Volume by Type (2025-2030) & (Kg)
Table 24. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2024)
Table 25. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2025-2030)
Table 26. Global Monoclonal Mouse Antibody Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Monoclonal Mouse Antibody Sales Value by Type (2019-2024) & (US$ Million)
Table 28. Global Monoclonal Mouse Antibody Sales Value by Type (2025-2030) & (US$ Million)
Table 29. Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2024)
Table 30. Global Monoclonal Mouse Antibody Sales Value Share by Type (2025-2030)
Table 31. Major Companies of Therapeutic
Table 32. Major Companies of Research
Table 33. Major Companies of Diagnostic
Table 34. Major Companies of ELISA kits
Table 35. Global Monoclonal Mouse Antibody Sales Volume by Application 2019 VS 2023 VS 2030 (Kg)
Table 36. Global Monoclonal Mouse Antibody Sales Volume by Application (2019-2024) & (Kg)
Table 37. Global Monoclonal Mouse Antibody Sales Volume by Application (2025-2030) & (Kg)
Table 38. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2024)
Table 39. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2025-2030)
Table 40. Global Monoclonal Mouse Antibody Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Monoclonal Mouse Antibody Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Monoclonal Mouse Antibody Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2024)
Table 44. Global Monoclonal Mouse Antibody Sales Value Share by Application (2025-2030)
Table 45. Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Table 46. Global Monoclonal Mouse Antibody Sales by Region (2019-2024) & (Kg)
Table 47. Global Monoclonal Mouse Antibody Sales Market Share by Region (2019-2024)
Table 48. Global Monoclonal Mouse Antibody Sales by Region (2025-2030) & (Kg)
Table 49. Global Monoclonal Mouse Antibody Sales Market Share by Region (2025-2030)
Table 50. Global Monoclonal Mouse Antibody Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Monoclonal Mouse Antibody Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Monoclonal Mouse Antibody Sales Value Share by Region (2019-2024)
Table 53. Global Monoclonal Mouse Antibody Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Monoclonal Mouse Antibody Sales Value Share by Region (2025-2030)
Table 55. Global Monoclonal Mouse Antibody Market Average Price (USD/g) by Region (2019-2024)
Table 56. Global Monoclonal Mouse Antibody Market Average Price (USD/g) by Region (2025-2030)
Table 57. Global Monoclonal Mouse Antibody Sales by Country: 2019 VS 2023 VS 2030 (Kg)
Table 58. Global Monoclonal Mouse Antibody Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Monoclonal Mouse Antibody Sales by Country (2019-2024) & (Kg)
Table 60. Global Monoclonal Mouse Antibody Sales Market Share by Country (2019-2024)
Table 61. Global Monoclonal Mouse Antibody Sales by Country (2025-2030) & (Kg)
Table 62. Global Monoclonal Mouse Antibody Sales Market Share by Country (2025-2030)
Table 63. Global Monoclonal Mouse Antibody Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Monoclonal Mouse Antibody Sales Value Market Share by Country (2019-2024)
Table 65. Global Monoclonal Mouse Antibody Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Monoclonal Mouse Antibody Sales Value Market Share by Country (2025-2030)
Table 67. Roche Company Information
Table 68. Roche Business Overview
Table 69. Roche Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 70. Roche Monoclonal Mouse Antibody Product Portfolio
Table 71. Roche Recent Development
Table 72. Johnson & Johnson Company Information
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 75. Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
Table 76. Johnson & Johnson Recent Development
Table 77. Merck Company Information
Table 78. Merck Business Overview
Table 79. Merck Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 80. Merck Monoclonal Mouse Antibody Product Portfolio
Table 81. Merck Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Business Overview
Table 84. Novartis Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 85. Novartis Monoclonal Mouse Antibody Product Portfolio
Table 86. Novartis Recent Development
Table 87. AbbVie Company Information
Table 88. AbbVie Business Overview
Table 89. AbbVie Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 90. AbbVie Monoclonal Mouse Antibody Product Portfolio
Table 91. AbbVie Recent Development
Table 92. Amgen Company Information
Table 93. Amgen Business Overview
Table 94. Amgen Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 95. Amgen Monoclonal Mouse Antibody Product Portfolio
Table 96. Amgen Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Business Overview
Table 99. Pfizer Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 100. Pfizer Monoclonal Mouse Antibody Product Portfolio
Table 101. Pfizer Recent Development
Table 102. Bayer Company Information
Table 103. Bayer Business Overview
Table 104. Bayer Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 105. Bayer Monoclonal Mouse Antibody Product Portfolio
Table 106. Bayer Recent Development
Table 107. Lilly Company Information
Table 108. Lilly Business Overview
Table 109. Lilly Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 110. Lilly Monoclonal Mouse Antibody Product Portfolio
Table 111. Lilly Recent Development
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 115. Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
Table 116. Bristol-Myers Squibb Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 120. GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
Table 121. GlaxoSmithKline Recent Development
Table 122. Biogen Company Information
Table 123. Biogen Business Overview
Table 124. Biogen Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 125. Biogen Monoclonal Mouse Antibody Product Portfolio
Table 126. Biogen Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Business Overview
Table 129. AstraZeneca Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 130. AstraZeneca Monoclonal Mouse Antibody Product Portfolio
Table 131. AstraZeneca Recent Development
Table 132. Sanofi Company Information
Table 133. Sanofi Business Overview
Table 134. Sanofi Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 135. Sanofi Monoclonal Mouse Antibody Product Portfolio
Table 136. Sanofi Recent Development
Table 137. Alexion Pharmaceuticals Company Information
Table 138. Alexion Pharmaceuticals Business Overview
Table 139. Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 140. Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
Table 141. Alexion Pharmaceuticals Recent Development
Table 142. Seattle Genetics Company Information
Table 143. Seattle Genetics Business Overview
Table 144. Seattle Genetics Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 145. Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
Table 146. Seattle Genetics Recent Development
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Monoclonal Mouse Antibody Distributors List
Table 150. Monoclonal Mouse Antibody Customers List
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources
Table 1. Monoclonal Mouse Antibody Industry Trends
Table 2. Monoclonal Mouse Antibody Industry Drivers
Table 3. Monoclonal Mouse Antibody Industry Opportunities and Challenges
Table 4. Monoclonal Mouse Antibody Industry Restraints
Table 5. Global Monoclonal Mouse Antibody Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Monoclonal Mouse Antibody Revenue Share by Company (2019-2024)
Table 7. Global Monoclonal Mouse Antibody Sales Volume by Company (Kg) & (2019-2024)
Table 8. Global Monoclonal Mouse Antibody Sales Volume Share by Company (2019-2024)
Table 9. Global Monoclonal Mouse Antibody Average Price (USD/g) of Company (2019-2024)
Table 10. Global Monoclonal Mouse Antibody Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Monoclonal Mouse Antibody Key Company Manufacturing Base & Headquarters
Table 12. Global Monoclonal Mouse Antibody Company, Product Type & Application
Table 13. Global Monoclonal Mouse Antibody Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Monoclonal Mouse Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of IgM
Table 18. Major Companies of IgG
Table 19. Major Companies of IgA
Table 20. Major Companies of Others
Table 21. Global Monoclonal Mouse Antibody Sales Volume by Type 2019 VS 2023 VS 2030 (Kg)
Table 22. Global Monoclonal Mouse Antibody Sales Volume by Type (2019-2024) & (Kg)
Table 23. Global Monoclonal Mouse Antibody Sales Volume by Type (2025-2030) & (Kg)
Table 24. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2024)
Table 25. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2025-2030)
Table 26. Global Monoclonal Mouse Antibody Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Monoclonal Mouse Antibody Sales Value by Type (2019-2024) & (US$ Million)
Table 28. Global Monoclonal Mouse Antibody Sales Value by Type (2025-2030) & (US$ Million)
Table 29. Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2024)
Table 30. Global Monoclonal Mouse Antibody Sales Value Share by Type (2025-2030)
Table 31. Major Companies of Therapeutic
Table 32. Major Companies of Research
Table 33. Major Companies of Diagnostic
Table 34. Major Companies of ELISA kits
Table 35. Global Monoclonal Mouse Antibody Sales Volume by Application 2019 VS 2023 VS 2030 (Kg)
Table 36. Global Monoclonal Mouse Antibody Sales Volume by Application (2019-2024) & (Kg)
Table 37. Global Monoclonal Mouse Antibody Sales Volume by Application (2025-2030) & (Kg)
Table 38. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2024)
Table 39. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2025-2030)
Table 40. Global Monoclonal Mouse Antibody Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Monoclonal Mouse Antibody Sales Value by Application (2019-2024) & (US$ Million)
Table 42. Global Monoclonal Mouse Antibody Sales Value by Application (2025-2030) & (US$ Million)
Table 43. Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2024)
Table 44. Global Monoclonal Mouse Antibody Sales Value Share by Application (2025-2030)
Table 45. Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Table 46. Global Monoclonal Mouse Antibody Sales by Region (2019-2024) & (Kg)
Table 47. Global Monoclonal Mouse Antibody Sales Market Share by Region (2019-2024)
Table 48. Global Monoclonal Mouse Antibody Sales by Region (2025-2030) & (Kg)
Table 49. Global Monoclonal Mouse Antibody Sales Market Share by Region (2025-2030)
Table 50. Global Monoclonal Mouse Antibody Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 51. Global Monoclonal Mouse Antibody Sales Value by Region (2019-2024) & (US$ Million)
Table 52. Global Monoclonal Mouse Antibody Sales Value Share by Region (2019-2024)
Table 53. Global Monoclonal Mouse Antibody Sales Value by Region (2025-2030) & (US$ Million)
Table 54. Global Monoclonal Mouse Antibody Sales Value Share by Region (2025-2030)
Table 55. Global Monoclonal Mouse Antibody Market Average Price (USD/g) by Region (2019-2024)
Table 56. Global Monoclonal Mouse Antibody Market Average Price (USD/g) by Region (2025-2030)
Table 57. Global Monoclonal Mouse Antibody Sales by Country: 2019 VS 2023 VS 2030 (Kg)
Table 58. Global Monoclonal Mouse Antibody Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Monoclonal Mouse Antibody Sales by Country (2019-2024) & (Kg)
Table 60. Global Monoclonal Mouse Antibody Sales Market Share by Country (2019-2024)
Table 61. Global Monoclonal Mouse Antibody Sales by Country (2025-2030) & (Kg)
Table 62. Global Monoclonal Mouse Antibody Sales Market Share by Country (2025-2030)
Table 63. Global Monoclonal Mouse Antibody Sales Value by Country (2019-2024) & (US$ Million)
Table 64. Global Monoclonal Mouse Antibody Sales Value Market Share by Country (2019-2024)
Table 65. Global Monoclonal Mouse Antibody Sales Value by Country (2025-2030) & (US$ Million)
Table 66. Global Monoclonal Mouse Antibody Sales Value Market Share by Country (2025-2030)
Table 67. Roche Company Information
Table 68. Roche Business Overview
Table 69. Roche Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 70. Roche Monoclonal Mouse Antibody Product Portfolio
Table 71. Roche Recent Development
Table 72. Johnson & Johnson Company Information
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 75. Johnson & Johnson Monoclonal Mouse Antibody Product Portfolio
Table 76. Johnson & Johnson Recent Development
Table 77. Merck Company Information
Table 78. Merck Business Overview
Table 79. Merck Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 80. Merck Monoclonal Mouse Antibody Product Portfolio
Table 81. Merck Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Business Overview
Table 84. Novartis Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 85. Novartis Monoclonal Mouse Antibody Product Portfolio
Table 86. Novartis Recent Development
Table 87. AbbVie Company Information
Table 88. AbbVie Business Overview
Table 89. AbbVie Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 90. AbbVie Monoclonal Mouse Antibody Product Portfolio
Table 91. AbbVie Recent Development
Table 92. Amgen Company Information
Table 93. Amgen Business Overview
Table 94. Amgen Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 95. Amgen Monoclonal Mouse Antibody Product Portfolio
Table 96. Amgen Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Business Overview
Table 99. Pfizer Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 100. Pfizer Monoclonal Mouse Antibody Product Portfolio
Table 101. Pfizer Recent Development
Table 102. Bayer Company Information
Table 103. Bayer Business Overview
Table 104. Bayer Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 105. Bayer Monoclonal Mouse Antibody Product Portfolio
Table 106. Bayer Recent Development
Table 107. Lilly Company Information
Table 108. Lilly Business Overview
Table 109. Lilly Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 110. Lilly Monoclonal Mouse Antibody Product Portfolio
Table 111. Lilly Recent Development
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 115. Bristol-Myers Squibb Monoclonal Mouse Antibody Product Portfolio
Table 116. Bristol-Myers Squibb Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 120. GlaxoSmithKline Monoclonal Mouse Antibody Product Portfolio
Table 121. GlaxoSmithKline Recent Development
Table 122. Biogen Company Information
Table 123. Biogen Business Overview
Table 124. Biogen Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 125. Biogen Monoclonal Mouse Antibody Product Portfolio
Table 126. Biogen Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Business Overview
Table 129. AstraZeneca Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 130. AstraZeneca Monoclonal Mouse Antibody Product Portfolio
Table 131. AstraZeneca Recent Development
Table 132. Sanofi Company Information
Table 133. Sanofi Business Overview
Table 134. Sanofi Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 135. Sanofi Monoclonal Mouse Antibody Product Portfolio
Table 136. Sanofi Recent Development
Table 137. Alexion Pharmaceuticals Company Information
Table 138. Alexion Pharmaceuticals Business Overview
Table 139. Alexion Pharmaceuticals Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 140. Alexion Pharmaceuticals Monoclonal Mouse Antibody Product Portfolio
Table 141. Alexion Pharmaceuticals Recent Development
Table 142. Seattle Genetics Company Information
Table 143. Seattle Genetics Business Overview
Table 144. Seattle Genetics Monoclonal Mouse Antibody Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 145. Seattle Genetics Monoclonal Mouse Antibody Product Portfolio
Table 146. Seattle Genetics Recent Development
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Monoclonal Mouse Antibody Distributors List
Table 150. Monoclonal Mouse Antibody Customers List
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources
LIST OF FIGURES
Figure 1. Monoclonal Mouse Antibody Product Picture
Figure 2. Global Monoclonal Mouse Antibody Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Monoclonal Mouse Antibody Sales (2019-2030) & (Kg)
Figure 5. Global Monoclonal Mouse Antibody Sales Average Price (USD/g) & (2019-2030)
Figure 6. Global Monoclonal Mouse Antibody Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. IgM Picture
Figure 10. IgG Picture
Figure 11. IgA Picture
Figure 12. Others Picture
Figure 13. Global Monoclonal Mouse Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 14. Global Monoclonal Mouse Antibody Sales Volume Share 2019 VS 2023 VS 2030
Figure 15. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2030)
Figure 16. Global Monoclonal Mouse Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Monoclonal Mouse Antibody Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2030)
Figure 19. Therapeutic Picture
Figure 20. Research Picture
Figure 21. Diagnostic Picture
Figure 22. ELISA kits Picture
Figure 23. Global Monoclonal Mouse Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 24. Global Monoclonal Mouse Antibody Sales Volume Share 2019 VS 2023 VS 2030
Figure 25. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2030)
Figure 26. Global Monoclonal Mouse Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Monoclonal Mouse Antibody Sales Value Share 2019 VS 2023 VS 2030
Figure 28. Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2030)
Figure 29. Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 30. Global Monoclonal Mouse Antibody Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. Global Monoclonal Mouse Antibody Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 32. Global Monoclonal Mouse Antibody Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 34. North America Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Europe Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 36. Europe Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Asia-Pacific Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Latin America Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 40. Latin America Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 41. Middle East & Africa Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 43. USA Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. USA Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. USA Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Canada Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Canada Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Canada Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Germany Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Germany Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51
Figure 1. Monoclonal Mouse Antibody Product Picture
Figure 2. Global Monoclonal Mouse Antibody Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Monoclonal Mouse Antibody Sales (2019-2030) & (Kg)
Figure 5. Global Monoclonal Mouse Antibody Sales Average Price (USD/g) & (2019-2030)
Figure 6. Global Monoclonal Mouse Antibody Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. IgM Picture
Figure 10. IgG Picture
Figure 11. IgA Picture
Figure 12. Others Picture
Figure 13. Global Monoclonal Mouse Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 14. Global Monoclonal Mouse Antibody Sales Volume Share 2019 VS 2023 VS 2030
Figure 15. Global Monoclonal Mouse Antibody Sales Volume Share by Type (2019-2030)
Figure 16. Global Monoclonal Mouse Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Monoclonal Mouse Antibody Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Monoclonal Mouse Antibody Sales Value Share by Type (2019-2030)
Figure 19. Therapeutic Picture
Figure 20. Research Picture
Figure 21. Diagnostic Picture
Figure 22. ELISA kits Picture
Figure 23. Global Monoclonal Mouse Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 24. Global Monoclonal Mouse Antibody Sales Volume Share 2019 VS 2023 VS 2030
Figure 25. Global Monoclonal Mouse Antibody Sales Volume Share by Application (2019-2030)
Figure 26. Global Monoclonal Mouse Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Monoclonal Mouse Antibody Sales Value Share 2019 VS 2023 VS 2030
Figure 28. Global Monoclonal Mouse Antibody Sales Value Share by Application (2019-2030)
Figure 29. Global Monoclonal Mouse Antibody Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 30. Global Monoclonal Mouse Antibody Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. Global Monoclonal Mouse Antibody Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 32. Global Monoclonal Mouse Antibody Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 33. North America Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 34. North America Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Europe Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 36. Europe Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Asia-Pacific Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 39. Latin America Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 40. Latin America Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 41. Middle East & Africa Monoclonal Mouse Antibody Sales Value (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Monoclonal Mouse Antibody Sales Value Share by Country (%), 2023 VS 2030
Figure 43. USA Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. USA Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. USA Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Canada Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Canada Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Canada Monoclonal Mouse Antibody Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. Germany Monoclonal Mouse Antibody Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. Germany Monoclonal Mouse Antibody Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51
